From a clinical point of view, parkin mutations cause PD characterized by slow progression, dystonia, and typical levodopa response, while non-motor features like olfactory dysfunction and cognitive impairment are less frequent compared to iPD [31]. Here, PRKN is linked to Parkinson disease.